Costa share price in focus following half year results

The Costa Group Holdings Ltd (ASX:CGC) share price will be on watch on Friday following the release of its half year update…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Costa Group Holdings Ltd (ASX: CGC) share price will be in focus this morning following the release of the horticulture company's half year results.

How did Costa perform in the first half?

Costa was finally back on form during the first half of FY 2020 and delivered solid revenue and profit growth.

For the six months ended 28 June 2020, Costa posted revenue of $612.4 million. This was an increase of 6.8% on the prior corresponding period.

Thanks largely to a strong performance from its international business, which offset weakness in its Produce segment, Costa's earnings before interest, tax, depreciation, and amortisation before self-generating and regenerating assets, leasing, and material items (EBITDA–SL) grew at a quicker rate.

Costa reported first half EBITDA–SL of $93.7 million, up 13.7% from $82.4 million during the prior corresponding period. This comprises EBITDA-SL of $62.1 million from its International segment (up 98%), EBITDA-SL of $28.6 million from the Produce segment (down 40.5%), and EBITDA-SL of $3.1 million from the Farms and Logistics segment (up 1.4%).

As a comparison, according to a note out of Goldman Sachs, it was expecting EBITDA-SL to come in at $108 million for the half.

On the bottom line, Costa reported a net profit after tax–SL of $45.8 million. This is an increase of 12% on the prior corresponding period.

In light of this return to form and a better than expected net debt leverage of 1.66x, the Costa board has declared a fully franked 4 cents per share interim dividend.

Management commentary.

Costa Group's CEO, Harry Debney, was pleased with the company's performance in FY 2020.

He said: "Our international segment performed strongly over the half, with significant improvement in EBITDASL, reflected in growth of 98% compared to the first half CY19. The major northern Morocco harvest cycle returned to normal timing and yield from all of our China farms was exceptional."

"The continued impact of CY19 adverse weather and drought conditions affected our first half CY20 results for our Australian operations. However, these historical conditions should have no material impact in 2HCY20 or beyond and there is broad based forward momentum in demand and pricing over our Australian portfolio leading into the second half of CY20," he added.

The chief executive notes that its citrus orchards are performing well in respect to size and yield, despite facing a number of challenges.

He commented: "We have been impressed with the relative performance of our citrus orchards in terms of fruit size and yield, especially given the circumstances where industry harvest volumes have been impacted due to previous heat events. Also, strong export and domestic demand, together with improved pricing levels are expected to continue to season end."

Outlook.

No guidance was given for the full year, but management appears positive on its prospects.

It notes that Australian market conditions across its portfolio are showing sizeable improvement and expects it to drive increased earnings into the second half.

It also advised that strong export and domestic demand and pricing in citrus, together with increased second half harvest timing, should be supportive of an improved outcome.

Management concluded: "Over the next three years given all major capex will be in place, this along with continued innovation will be the platform to drive quality, yield growth and shareholder returns. This is supported by strong balance sheet and cashflow generation, placing the company in a position to continue growth as a low cost producer, while capitalising on opportunities as they arise."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended COSTA GRP FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rough start to the trading week this Monday.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Forget CBA shares and buy this ASX ETF: experts

Here's what experts are saying about these two investment options.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Buy, hold, sell: BHP, Guzman Y Gomez, and Pro Medicus shares

Are brokers bullish or bearish on these names? Let's find out.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Humanoid robot analysing the stock market, symbolising artificial intelligence shares.
Broker Notes

Up 109% since November, are Appen shares still a buy today?

A leading expert digs into the outlook for Appen shares amid the rise of AI.

Read more »

Paper aeroplane going down on a chart, symbolising a falling share price.
Travel Shares

Why Web Travel shares are sliding as fresh takeover hopes return

Web Travel shares sink as investors weigh CEO succession and takeover risk.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 4DMedical, Brainchip, Catapult, and Star Entertainment shares are falling today

These shares are starting the week in the red. But why>

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »